KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Payables (2022 - 2025)

Historic Payables for QuidelOrtho (QDEL) over the last 4 years, with Q3 2025 value amounting to $213.7 million.

  • QuidelOrtho's Payables fell 1355.18% to $213.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $213.7 million, marking a year-over-year decrease of 1355.18%. This contributed to the annual value of $246.0 million for FY2024, which is 1655.36% down from last year.
  • Per QuidelOrtho's latest filing, its Payables stood at $213.7 million for Q3 2025, which was down 1355.18% from $218.8 million recorded in Q2 2025.
  • QuidelOrtho's 5-year Payables high stood at $294.8 million for Q4 2023, and its period low was $101.5 million during Q1 2022.
  • Over the past 4 years, QuidelOrtho's median Payables value was $241.8 million (recorded in 2022), while the average stood at $235.5 million.
  • Per our database at Business Quant, QuidelOrtho's Payables skyrocketed by 17911.33% in 2023 and then plummeted by 1655.36% in 2024.
  • QuidelOrtho's Payables (Quarter) stood at $241.8 million in 2022, then rose by 21.92% to $294.8 million in 2023, then fell by 16.55% to $246.0 million in 2024, then decreased by 13.13% to $213.7 million in 2025.
  • Its last three reported values are $213.7 million in Q3 2025, $218.8 million for Q2 2025, and $230.9 million during Q1 2025.